Cuprina Holdings appoints Sherman as Medical, Scientific Director

Cuprina announced that Dr. Ronald Sherman has agreed to join the Company as Medical and Scientific Director in September 2025. Cuprina also announced it has signed an agreement with Dr. Sherman licensing his 2004 FDA clearance to market Lucilia sericata Medical Maggots. This agreement gives Cuprina the right to manufacture, sell, use and distribute these maggots and associated dressings for use in maggot debridement therapy in the United States.